top of page
Hope4ATRT_Logo_small.png

Tazemetostat: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Summary

Trial Information

Approach

Additional Information

Eligibility

Contact Information

Hope4ATRT Foundation

is a research entity of Out of Zion, Inc.

IRS Code: Section 501(c)(3). Tax ID #81-5022992

Mailing Address: 

PO Box 46713

Tampa, FL  33646

bottom of page